Telavancin
- TRADE NAME: Vibativ (Astellas)
- INDICATIONS: Complicated skin and skin structure infections (cSSSI)
- CLASS: Antibiotic, Antibiotic; lipoglycopeptide, Antimicrobial
- HALF-LIFE: 7–10 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Alfuzosin, Artemether/Lumefantrine, BCG Vaccine, Chloroquine, Ciprofloxacin, Dronedarone, Gadobutrol, Indacaterol, Nilotinib, Pimozide, QT prolonging agents, Quetiapine, Quinine, Tetrabenazine, Thioridazine, Toremifene, Typhoid Vaccine, Vandetanib, Vemurafenib, Ziprasidone
PREGNANCY CATEGORY: C
Contra-indicated in patients with known hypersensitivity to vancomycin.
FETAL RISK
See full prescribing information for complete boxed warning.
Please login to see the rest of this drug profile
SKIN.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
GENITOURINARY.
HEMATOLOGIC.
LOCAL.
RENAL.
RESPIRATORY.
OTHER.
Page last updated 07/31/2023
Symbol key
Incidence
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric